805 results on '"Chilosi, M"'
Search Results
102. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies
103. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease
104. Lymphoproliferative lung disorders: clinicopathological aspects
105. Heterogeneous distribution of mechanical stress in human lung: A mathematical approach to evaluate abnormal remodeling in IPF
106. Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications
107. P21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin’s lymphomas and Hodgkin’s disease: a reliable marker of p53 tumor suppressor gene function
108. Immunohistochemical and flow cytometric analysis of the expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia
109. The role of transbronchial biopsy in the diagnosis of diffuse parenchymal lung diseases: Pro
110. Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large cell lymphoma
111. Pulmonary features of Birt-Hogg-Dubé syndrome: Cystic lesions and pulmonary histiocytoma
112. Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
113. Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis
114. Immunology and immunohistology of sarcoidosis
115. CD30 antigen and cellular biology of Reed-Sternberg cells
116. Detection of membrane and intracellular antigens by flow cytometry following ORTHO PermeaFixTM fixation
117. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis
118. Circulating soluble ICAM-1 in patients with Hodgkin's disease
119. Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis
120. Prospective evaluation of drug-induced lung toxicity with high-resolution CT and transbronchial biopsy
121. Role of human tissue kallikrein in gastrointestinal stromal tumour invasion
122. Pulmonary immune cells in healthy and disease. Lymphocytes
123. Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues
124. Birt-Hogg-Dubè Syndrome, Report of Two Novel Mutations and a Rare Tumor of the Lung.
125. Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage
126. Transbronchial biopsy in sarcoidosis: the role of immunohistochemical analysis for granuloma detection
127. Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts
128. Independent prognostic value of fascin immunoreactivity in stage III–IV colonic adenocarcinoma
129. Serum interleukin-2 receptor as index of tumor burden in hairy cell leukemia
130. Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age
131. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor
132. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series
133. CDX-2 Homeobox Gene Expression Is a Reliable Marker of Colorectal Adenocarcinoma Metastases to the Lungs
134. Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase
135. 1183PD - Risk Stratification Model for Resected Squamous Cell Lung Cancer (R-Sqlc) Patients (Pts) According to Clinical and Pathological Factors
136. Acute interstitial pneumonia: report of a series
137. Heparan Sulfate Glycosaminoglycans Are Receptors Sufficient To Mediate the Initial Binding of Adenovirus Types 2 and 5
138. Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors
139. Ormond's disease: Aspetti anatomo-patologici: Ormond's disease: Histopathological features
140. 28 Basal and TNF-alpha stimulated production of PAI-1 by human adipose tissue in culture
141. Expression of extracellular matrix molecules, proliferation markers and cyclin-dependent kinase inhibitors in inflamed tissues
142. p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function
143. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease
144. Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma.
145. Immunohistochemical evidence of abnormal expression of MDM2 and p53 in Hodgkin's disease
146. Inducible nitric oxide synthase expression on human monocyte-derived cells in granulomatous reactions
147. Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease
148. CD30 antigen and cellular biology of Reed-Sternberg cells [letter; comment]
149. Pulmonary immune cells in health and disease: lymphocytes
150. ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.